Skip to content
2000
image of An Advanced Network Pharmacology Study Reveals the Multi-Pathway and Multi-Gene Regulatory Mechanism of Jinbai Heat-clearing Prescription in HPV-induced Cervical Cancer via Molecular Docking and Microarray Data Analysis

Abstract

Introduction

Cervical cancer, primarily driven by high-risk human papillomavirus (HPV) infection, remains a global health challenge due to limited therapeutic efficacy and adverse effects of conventional treatments. Jinbai Heat-Clearing Prescription (JBHCP), a Traditional Chinese Medicine (TCM), exhibits potential against HPV-associated cervical cancer, yet its molecular mechanisms are unclear. This study aimed to elucidate JBHCP’s multitarget regulatory mechanisms in HPV-induced cervical carcinogenesis.

Methods

Network pharmacology, UHPLC-Q-TOF-MS-based metabolomics, and microarray data analysis were integrated to identify the bioactive components and therapeutic targets of JBHCP. Molecular docking and 60 ns Molecular Dynamics (MD) simulations were used to assess the interactions between key compounds (JBHCP673, JBHCP727) and cyclin-dependent kinases (CDK1/CDK2). Gene Ontology (GO), KEGG pathway enrichment, and Protein-Protein Interaction (PPI) network analyses were performed to explore biological functions and signaling pathways.

Results

UHPLC-Q-TOF-MS identified 816 compounds in JBHCP, with 86 meeting drug-likeness criteria. Network analysis revealed 215 shared targets between JBHCP and HPV-induced cervical cancer, including CDK1 and CDK2 as core regulators. Enrichment analysis highlighted JBHCP’s involvement in cell cycle regulation, PI3K/AKT, and STAT3 signaling pathways. Molecular docking demonstrated strong binding affinities of JBHCP727 with CDK1 (-7.36 kcal/mol) and CDK2 (-6.13 kcal/mol). MD simulations confirmed stable binding of JBHCP727 to CDK1/2, while JBHCP673 exhibited instability. ADMET predictions supported JBHCP727’s drug-like properties.

Discussion

JBHCP exerts anticancer effects by targeting CDK1/2, disrupting cell cycle progression, and modulating oncogenic pathways (PI3K/AKT, STAT3). The stability of JBHCP727-CDK complexes suggests its role in inhibiting HPV-driven proliferation. Multi-component synergy enables JBHCP to act on diverse pathways, aligning with TCM’s “multitarget” paradigm.

Conclusion

This study provides the first systematic evidence of JBHCP’s multi-pathway mechanism against HPV-associated cervical cancer, emphasizing CDK1/2 inhibition as a key therapeutic strategy. JBHCP727 emerges as a promising lead compound. Further and clinical validation is warranted to translate these findings into clinical applications.

Loading

Article metrics loading...

/content/journals/cmc/10.2174/0109298673377164250710100915
2025-08-08
2025-11-04
Loading full text...

Full text loading...

References

  1. Buskwofie A. David-West G. Clare C.A. A review of cervical cancer: Incidence and disparities. J. Natl. Med. Assoc. 2020 112 2 229 232 10.1016/j.jnma.2020.03.002 32278478
    [Google Scholar]
  2. Chu D. Liu T. Yao Y. Implications of viral infections and oncogenesis in uterine cervical carcinoma etiology and pathogenesis. Front. Microbiol. 2023 14 1194431 10.3389/fmicb.2023.1194431 37293236
    [Google Scholar]
  3. Schubert M. Bauerschlag D.O. Muallem M.Z. Maass N. Alkatout I. Challenges in the diagnosis and individualized treatment of cervical cancer. Medicina 2023 59 5 925 10.3390/medicina59050925 37241157
    [Google Scholar]
  4. Shiri Aghbash P. Hemmat N. Baradaran B. Mokhtarzadeh A. Poortahmasebi V. Ahangar Oskuee M. Bannazadeh Baghi H. The effect of Wnt/β-catenin signaling on PD-1/PDL-1 axis in HPV-related cervical cancer. Oncol. Res. 2022 30 3 99 116 10.32604/or.2022.026776 37305016
    [Google Scholar]
  5. Cuschieri K. Fellner M.D. Arroyo Mühr L.S. Padalko E. Correa R.M. Dillner J. Gultekin M. Picconi M.A. Quality assurance in human papillomavirus testing for primary cervical screening. Int. J. Gynecol. Cancer 2023 33 5 802 811 10.1136/ijgc‑2022‑004197 36914171
    [Google Scholar]
  6. Ge Z.H. Xia J.W. Liu Q. Ran Q.Q. Zhu J.F. Yang Y.B. Study on the supply-demand barriers affecting cervical cancer screening and countermeasure analysis. J Med Theor Prac. 2022 35 1296 1298
    [Google Scholar]
  7. Grau-Bejar J.F. Garcia-Duran C. Garcia-Illescas D. Mirallas O. Oaknin A. Advances in immunotherapy for cervical cancer. Ther. Adv. Med. Oncol. 2023 15 17588359231163836 10.1177/17588359231163836 37007635
    [Google Scholar]
  8. Sagae S. Toita T. Matsuura M. Saito M. Matsuda T. Sato N. Shimizu A. Endo T. Fujii M. Gaffney D.K. Small W. Jr. Improvement in radiation techniques for locally advanced cervical cancer during the last two decades. Int. J. Gynecol. Cancer 2023 33 8 1295 1303 10.1136/ijgc‑2022‑004230 37041022
    [Google Scholar]
  9. Golshani G. Zhang Y. Advances in immunotherapy for colorectal cancer: A review. Therap. Adv. Gastroenterol. 2020 13 1756284820917527 10.1177/1756284820917527 32536977
    [Google Scholar]
  10. Astillero-Lopez V. Villar-Conde S. Gonzalez-Rodriguez M. Flores-Cuadrado A. Ubeda-Banon I. Saiz-Sanchez D. Martinez-Marcos A. Proteomic analysis identifies HSP90AA1 , PTK2B, and ANXA2 in the human entorhinal cortex in Alzheimer’s disease: Potential role in synaptic homeostasis and Aβ pathology through microglial and astroglial cells. Brain Pathol. 2024 34 4 e13235 10.1111/bpa.13235 38247340
    [Google Scholar]
  11. Han F.J. Jiang T.T. Zhang M. Study on the function and mechanism of traditional Chinese medicine in the treatment of cervical cancer. J Tianjin Univ Tradit Chin Med 2018 37 80 83
    [Google Scholar]
  12. Wang Z. Chen Y.Y. Zhang Y.Y. Wu P. Wang J. Problems and solutions in study of multi-component and multi-target mechanism of action of traditional chinese medicine. Chin. J. Exp. Trad. Med. Formul. 2018 24 1 6
    [Google Scholar]
  13. Zhang K.J. Li J.S. Clinical study on external wash with Kushen Baibu Huangbai Decoction combined with antibiotics for bacterial vaginitis. NCIM 2023 55 99 103
    [Google Scholar]
  14. Yang L.T. Cao Q. Chen X.H. Pan Y.J. Effects of fufang huangbaiye liniment combined with VSD on inflammatory factors and foot blood supply of patients with wagner grade 2,3 diabetic foot. Med. Innov. China 2023 20 71 74 10.3969/j.issn.1674‑4985.2023.30.017
    [Google Scholar]
  15. He X.L. Wang G.D. Pu T. Efficacy and safety of fumigation with Compound Phellodendron Amurense Liquid combined with inter-sphinctericapproach in the treatment of perianal abscesses. Hainan Medicine. 2023 18 2631 2635
    [Google Scholar]
  16. Jiang Z. Mou J. Feng J. Zhang S. Li D. Liu Y. Comparative analysis of volatile components in chi-nan and ordinary agarwood aromatherapies: Implications for sleep improvement. Pharmaceuticals 2024 17 9 1196 1196 10.3390/ph17091196 39338358
    [Google Scholar]
  17. Chen N. Xia Y. Wu W. Chen S. Zhao M. Song Y. Liu Y. Exploring the mechanism of agarwood moxa smoke in treating sleep disorders based on GC–MS and network pharmacology. Front. Med. 2024 11 1400334 10.3389/fmed.2024.1400334 38784223
    [Google Scholar]
  18. Huang J. Osthushenrich T. MacNamara A. Mälarstig A. Brocchetti S. Bradberry S. Scarabottolo L. Ferrada E. Sosnin S. Digles D. Superti-Furga G. Ecker G.F. ProteoMutaMetrics: Machine learning approaches for solute carrier family 6 mutation pathogenicity prediction. RSC Advances 2024 14 19 13083 13094 10.1039/D4RA00748D 38655474
    [Google Scholar]
  19. Patil N. Dhariwal R. Mohammed A. Wei L.S. Jain M. Network pharmacology-based approach to elucidate the pharmacologic mechanisms of natural compounds from Dictyostelium discoideum for Alzheimer’s disease treatment. Heliyon 2024 10 8 e28852 10.1016/j.heliyon.2024.e28852 38644825
    [Google Scholar]
  20. Gong H. Xia Y. Jing G. Yuan M. Zhou H. Wu D. Zuo J. Lei C. Aidebaike D. Wu X. Song X. Berberine alleviates neuroinflammation by downregulating NFκB/LCN2 pathway in sepsis-associated encephalopathy: Network pharmacology, bioinformatics, and experimental validation. Int. Immunopharmacol. 2024 133 112036 10.1016/j.intimp.2024.112036 38640713
    [Google Scholar]
  21. Etarhouni M. Moorthy H.P. Chong B. Design of novel differential power processing scheme for small-scale PV array application operating under partial shading conditions: Modelling and experimental validation. Comput. Electr. Eng. 2024 117 109254 10.1016/j.compeleceng.2024.109254
    [Google Scholar]
  22. Shboul M. Bani Domi A. Abu Zahra A. Khasawneh A.G. Darweesh R. Plasma miRNAs as potential biomarkers for schizophrenia in a Jordanian cohort. Noncoding RNA Res. 2024 9 2 350 358 10.1016/j.ncrna.2024.01.018 38511065
    [Google Scholar]
  23. de Saxe C. Ainalis D. Cebon D. A dataset of logistics sites in England and Wales: Location, size, type and loading bays. Data Brief 2024 54 110399 10.1016/j.dib.2024.110399 38690322
    [Google Scholar]
  24. Akbari V. Kallhor M. Mollashahi B. Movafagh A. Transcriptome and network dissection of microsatellite stable and highly instable colorectal cancer. Asian Pac. J. Cancer Prev. 2019 20 8 2445 2454 10.31557/APJCP.2019.20.8.2445 31450919
    [Google Scholar]
  25. He D. Wang R. Xu Z. Wang J. Song P. Wang H. Su J. The use of artificial intelligence in the treatment of rare diseases: A scoping review. Intractable Rare Dis. Res. 2024 13 1 12 22 10.5582/irdr.2023.01111 38404730
    [Google Scholar]
  26. Li Z. Wang S. Sun M. Jin M. Khain D. Yang Q. Comprehensive parameter space mapping of cell cycle dynamics under network perturbations. ACS Synth. Biol. 2024 13 3 804 815 10.1021/acssynbio.3c00631 38420905
    [Google Scholar]
  27. Zhang Y. Xue Y. Zeng J. Wu H. Yang Y. Oxyepiberberine from the active site of coptidis rhizoma inhibits lung adenocarcinoma by regulating src-related pathways in vivo. Pharmacogn. Mag. 2024 20 2 572 584 10.1177/09731296231213147
    [Google Scholar]
  28. Li X. Wang J. Liao C. Yang X. Zhao Z. Liu Y. Xue Q. Luo Y. Liu X. Liu Z. The binding of PKCε and MEG2 to STAT3 regulates IL-6-mediated microglial hyperalgesia during inflammatory pain. FASEB J. 2024 38 8 e23590 10.1096/fj.202300152RR 38656553
    [Google Scholar]
  29. Ding H. Yan L. Wang Y. Lu Y. Deng M. Wang Y. Wang Q. Zhou X. Astaxanthin attenuates cigarette smoke-induced small airway remodeling via the AKT1 signaling pathway. Respir. Res. 2024 25 1 148 10.1186/s12931‑024‑02768‑4 38555458
    [Google Scholar]
  30. Ding L. Jiang H. Li Q. Li Q. Zhang T.T. Shang L. Xie B. Zhu Y. Ding K. Shi X. Zhu T. Zhu Y. Ropivacaine as a novel AKT1 specific inhibitor regulates the stemness of breast cancer. J. Exp. Clin. Cancer Res. 2024 43 1 90 10.1186/s13046‑024‑03016‑9 38523299
    [Google Scholar]
  31. Yang Y. Huang L. Zhang N. Deng Y.N. Cao X. Liang Y. Hou H. Luo Y. Yang Y. Li Q. Liang S. SUMOylation of annexin A6 retards cell migration and tumor growth by suppressing RHOU/AKT1–involved EMT in hepatocellular carcinoma. Cell Commun. Signal. 2024 22 1 206 10.1186/s12964‑024‑01573‑2 38566133
    [Google Scholar]
  32. Ye C. Zhang B. Tang Z. Zheng C. Wang Q. Tong X. Synergistic action of Hedyotis diffusa Willd and Andrographis paniculata in Nasopharyngeal Carcinoma: Downregulating AKT1 and upregulating VEGFA to curb tumorigenesis. Int. Immunopharmacol. 2024 132 111866 10.1016/j.intimp.2024.111866 38603854
    [Google Scholar]
  33. Yao Y. Li X. Yang X. Mou H. Wei L. Indirubin, an active component of indigo naturalis, exhibits inhibitory effects on leukemia cells via targeting HSP90AA1 and PI3K/AKT pathway. Anticancer. Agents Med. Chem. 2024 24 9 718 727 10.2174/0118715206258293231017063340 38347773
    [Google Scholar]
  34. Ezelarab H.A.A. Abd El-Hafeez A.A. Ali T.F.S. Sayed A.M. Hassan H.A. Beshr E.A.M. Abbas S.H. New 2-oxoindole derivatives as multiple PDGFRα/ß and VEGFR-2 tyrosine kinase inhibitors. Bioorg. Chem. 2024 145 107234 10.1016/j.bioorg.2024.107234 38412650
    [Google Scholar]
  35. Li G. Yan K. Zhang W. Pan H. Guo P. ARDS and aging: TYMS emerges as a promising biomarker and therapeutic target. Front. Immunol. 2024 15 1365206 10.3389/fimmu.2024.1365206 38558817
    [Google Scholar]
  36. Li Z. Li M. Xiao L. Zheng X. Li R. Dong S. Wang Y. Wen H. Ruan K. Cheng K. Chen M. Tan Y. 6-O-angeloylplenolin inhibits osteoclastogenesis in vitro via suppressing c-Src/NF-κB/NFATc1 pathways and ameliorates bone resorption in collagen-induced arthritis mouse model. Biochem. Pharmacol. 2024 224 116230 10.1016/j.bcp.2024.116230 38643905
    [Google Scholar]
  37. Chatterjee A. Roy T. Jyothi D. Mishra V.K. Singh U.P. Swarnakar S. Melatonin inhibits AGS cell proliferation by binding to the ATP binding site of CDK2 under hyperglycemic conditions. Cell Biochem. Biophys. 2024 82 2 895 908 10.1007/s12013‑024‑01241‑9 38453745
    [Google Scholar]
  38. Cui X. Dong H. Luo S. Zhuang B. Li Y. Zhong C. Ma Y. Hong L. Long non-coding RNA-cardiac-inducing RNA 6 mediates repair of infarcted hearts by inducing mesenchymal stem cell differentiation into cardiogenic cells through cyclin-dependent kinase 1. Int. J. Mol. Sci. 2024 25 6 3466 10.3390/ijms25063466 38542439
    [Google Scholar]
  39. Gerosa R. De Sanctis R. Jacobs F. Benvenuti C. Gaudio M. Saltalamacchia G. Torrisi R. Masci G. Miggiano C. Agustoni F. Pedrazzoli P. Santoro A. Zambelli A. Cyclin-dependent kinase 2 (CDK2) inhibitors and others novel CDK inhibitors (CDKi) in breast cancer: Clinical trials, current impact, and future directions. Crit. Rev. Oncol. Hematol. 2024 196 104324 10.1016/j.critrevonc.2024.104324 38462150
    [Google Scholar]
  40. Chmielewska-Kassassir M. Sobierajska K. Ciszewski W.M. Kryczka J. Zieleniak A. Wozniak L.A. Evening primrose extract modulates tyms expression via SP1 transcription factor in malignant pleural mesothelioma. Cancers 2023 15 20 5003 10.3390/cancers15205003 37894370
    [Google Scholar]
  41. Liu H. Zhou J. Xie J. Fan L. Xia Y. Peng X. Du H. Ni X. Tanshinone IIA as a therapy for PCOS via FOS/JUN/TP53 axis: Evidence from network pharmacology of Bajitian-Danshen pair. Arab. J. Chem. 2024 17 4 105641 10.1016/j.arabjc.2024.105641
    [Google Scholar]
  42. Al-Kuraishy H.M. Al-Maiahy T.J. Al-Gareeb A.I. Alexiou A. Papadakis M. Saad H.M. Batiha G.E. The possible role furin and furin inhibitors in endometrial adenocarcinoma: A narrative review. Cancer Rep. 2024 7 1 e1920 10.1002/cnr2.1920 38018319
    [Google Scholar]
  43. Saad H.M. Tourky G.F. Al-kuraishy H.M. Al-Gareeb A.I. Khattab A.M. Elmasry S.A. Alsayegh A.A. Hakami Z.H. Alsulimani A. Sabatier J.M. Eid M.W. Shaheen H.M. Mohammed A.A. Batiha G.E.S. De Waard M. The potential role of MUC16 (CA125) biomarker in lung cancer: A magic biomarker but with adversity. Diagnostics 2022 12 12 2985 2985 10.3390/diagnostics12122985 36552994
    [Google Scholar]
  44. Sindhu R.K. Verma R. Salgotra T. Rahman M.H. Shah M. Akter R. Murad W. Mubin S. Bibi P. Qusti S. Alshammari E.M. Batiha G.E.S. Tomczyk M. Al-kuraishy H.M. Impacting the remedial potential of nano delivery-based flavonoids for breast cancer treatment. Molecules 2021 26 17 5163 5163 10.3390/molecules26175163 34500597
    [Google Scholar]
/content/journals/cmc/10.2174/0109298673377164250710100915
Loading
/content/journals/cmc/10.2174/0109298673377164250710100915
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.


  • Article Type:
    Research Article
Keywords: HPV ; molecular dynamics ; Cervical cancer ; Prescription ; microarray analysis ; Jinbai Heat-clearing
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test